KIT and acute myeloid leukemia: Mutations in genes that regulate the RAS-MAPK-ERK pathway, such as NRAS, KRAS, PTPN11, NF1, and KIT are commonly found in patients with AML, and RAS-MAPK-ERK signaling is often highly activated [140].